Biologics Spine Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds byTim AllenMarch 11, 2026
Biologics Spine Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery byJosh SandbergMarch 10, 2026
Biologics Spine Peer-Reviewed Publication Demonstrating Long-Term Fusion Outcomes with VIA Form+™ in Lumbar Interbody Fusion byJosh SandbergFebruary 12, 2026
Biologics Spine BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease byTim AllenFebruary 10, 2026
Biologics Top Stories XLTA® Announces Distributor Partnership with Total Ancillary, Expanding Access to Advanced Hydrocapillary Wound Care byJosh SandbergFebruary 4, 2026
Biologics Spine Top Stories Nivalon Medical Produces the World’s First Fully Patient-Specific, Motion-Preserving, Metal-Free Spinal Implant Using AI and Advanced Ceramic 3D Printing byJosh SandbergJanuary 30, 2026
Biologics Spine Study Shows NanoFuse® Superiority: Why Bioactive Glass-DBM Composites Outperform DBM and Bioactive Glass Alone byJosh SandbergJanuary 26, 2026
Biologics Spine Spine Biologic Market Report 2026 – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 byTim AllenJanuary 26, 2026
Biologics Royal Biologics Announces Exclusive U.S. Distribution Agreement with Aroa Biosurgery for Myriad Matrix™ Restore byTim AllenJanuary 15, 2026
Biologics Spine MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™ byJosh SandbergJanuary 14, 2026